IBDEI0Z5 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17136,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17136,1,4,0)
 ;;=4^V10.81
 ;;^UTILITY(U,$J,358.3,17136,1,5,0)
 ;;=5^HX OF BONE MALIGNANCY
 ;;^UTILITY(U,$J,358.3,17136,2)
 ;;=^295239
 ;;^UTILITY(U,$J,358.3,17137,0)
 ;;=V10.82^^88^1046^35
 ;;^UTILITY(U,$J,358.3,17137,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17137,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,17137,1,5,0)
 ;;=5^HX-MALIG SKIN MELANOMA
 ;;^UTILITY(U,$J,358.3,17137,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,17138,0)
 ;;=V10.83^^88^1046^42
 ;;^UTILITY(U,$J,358.3,17138,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17138,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,17138,1,5,0)
 ;;=5^HX-SKIN MALIGNANCY NEC
 ;;^UTILITY(U,$J,358.3,17138,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,17139,0)
 ;;=V10.84^^88^1046^6
 ;;^UTILITY(U,$J,358.3,17139,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17139,1,4,0)
 ;;=4^V10.84
 ;;^UTILITY(U,$J,358.3,17139,1,5,0)
 ;;=5^HX OF EYE MALIGNANCY
 ;;^UTILITY(U,$J,358.3,17139,2)
 ;;=^295242
 ;;^UTILITY(U,$J,358.3,17140,0)
 ;;=V10.85^^88^1046^3
 ;;^UTILITY(U,$J,358.3,17140,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17140,1,4,0)
 ;;=4^V10.85
 ;;^UTILITY(U,$J,358.3,17140,1,5,0)
 ;;=5^HX OF BRAIN MALIGNANCY
 ;;^UTILITY(U,$J,358.3,17140,2)
 ;;=^295243
 ;;^UTILITY(U,$J,358.3,17141,0)
 ;;=V10.86^^88^1046^36
 ;;^UTILITY(U,$J,358.3,17141,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17141,1,4,0)
 ;;=4^V10.86
 ;;^UTILITY(U,$J,358.3,17141,1,5,0)
 ;;=5^HX-MALIGN NERVE SYST NEC
 ;;^UTILITY(U,$J,358.3,17141,2)
 ;;=^295244
 ;;^UTILITY(U,$J,358.3,17142,0)
 ;;=V10.87^^88^1046^20
 ;;^UTILITY(U,$J,358.3,17142,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17142,1,4,0)
 ;;=4^V10.87
 ;;^UTILITY(U,$J,358.3,17142,1,5,0)
 ;;=5^HX OF THYROID MALIGNANCY
 ;;^UTILITY(U,$J,358.3,17142,2)
 ;;=^295245
 ;;^UTILITY(U,$J,358.3,17143,0)
 ;;=V10.88^^88^1046^24
 ;;^UTILITY(U,$J,358.3,17143,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17143,1,4,0)
 ;;=4^V10.88
 ;;^UTILITY(U,$J,358.3,17143,1,5,0)
 ;;=5^HX-ENDOCRINE MALIGN NEC
 ;;^UTILITY(U,$J,358.3,17143,2)
 ;;=^295246
 ;;^UTILITY(U,$J,358.3,17144,0)
 ;;=V10.89^^88^1046^16
 ;;^UTILITY(U,$J,358.3,17144,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17144,1,4,0)
 ;;=4^V10.89
 ;;^UTILITY(U,$J,358.3,17144,1,5,0)
 ;;=5^HX OF MALIGNANCY NEC
 ;;^UTILITY(U,$J,358.3,17144,2)
 ;;=^295247
 ;;^UTILITY(U,$J,358.3,17145,0)
 ;;=V45.71^^88^1047^7
 ;;^UTILITY(U,$J,358.3,17145,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17145,1,4,0)
 ;;=4^V45.71
 ;;^UTILITY(U,$J,358.3,17145,1,5,0)
 ;;=5^ACQUIRED ABSENCE OF BREAST
 ;;^UTILITY(U,$J,358.3,17145,2)
 ;;=^336882
 ;;^UTILITY(U,$J,358.3,17146,0)
 ;;=V45.72^^88^1047^6
 ;;^UTILITY(U,$J,358.3,17146,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17146,1,4,0)
 ;;=4^V45.72
 ;;^UTILITY(U,$J,358.3,17146,1,5,0)
 ;;=5^ACQ. ABS. OF INTESTINE (LG,SM)
 ;;^UTILITY(U,$J,358.3,17146,2)
 ;;=^317959
 ;;^UTILITY(U,$J,358.3,17147,0)
 ;;=V45.73^^88^1047^8
 ;;^UTILITY(U,$J,358.3,17147,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17147,1,4,0)
 ;;=4^V45.73
 ;;^UTILITY(U,$J,358.3,17147,1,5,0)
 ;;=5^ACQUIRED ABSENCE OF KIDNEY
 ;;^UTILITY(U,$J,358.3,17147,2)
 ;;=^317962
 ;;^UTILITY(U,$J,358.3,17148,0)
 ;;=V45.74^^88^1047^4
 ;;^UTILITY(U,$J,358.3,17148,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17148,1,4,0)
 ;;=4^V45.74
 ;;^UTILITY(U,$J,358.3,17148,1,5,0)
 ;;=5^ACQ ABSENCE ORG,URINARY TRACT
 ;;^UTILITY(U,$J,358.3,17148,2)
 ;;=^322063
 ;;^UTILITY(U,$J,358.3,17149,0)
 ;;=V45.75^^88^1047^3
 ;;^UTILITY(U,$J,358.3,17149,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17149,1,4,0)
 ;;=4^V45.75
 ;;^UTILITY(U,$J,358.3,17149,1,5,0)
 ;;=5^ACQ ABSENCE ORG,STOMACH
 ;;
 ;;$END ROU IBDEI0Z5
